Insider Transactions in Q1 2024 at Biocryst Pharmaceuticals Inc (BCRX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2024
|
Helen M. Thackray Chief R&D Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-3.01%
|
$37,625
$5.08 P/Share
|
|
Feb 29
2024
|
Vincent Milano Director |
BUY
Grant, award, or other acquisition
|
Direct |
999
+1.89%
|
$4,995
$5.63 P/Share
|
|
Feb 29
2024
|
Theresa Heggie Director |
BUY
Grant, award, or other acquisition
|
Direct |
999
+1.89%
|
$4,995
$5.63 P/Share
|
|
Jan 03
2024
|
Jon P Stonehouse President & CEO |
BUY
Bona fide gift
|
Indirect |
20,000
+33.33%
|
-
|
|
Jan 03
2024
|
Jon P Stonehouse President & CEO |
SELL
Bona fide gift
|
Direct |
20,000
-1.79%
|
-
|